Biomarkers for treatment selection in colon cancer
There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a growing number of new and improved targeted agents and efficacious combination regimens yielding substantial clinical benefits in both early and late stages of the diseases. Moreover, breakthroughs in molecular profiling, cancer immunology, early stage detection, and novel diagnostic techniques have led to accelerated strides in GI cancer research and management.
As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016.
In this presentation, Dr. Christopher H. Lieu discusses the use of biomarkers for colon cancer treatment selection.
Earn accreditation for this activity at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205
© 2016 Imedex, LLC.
Видео Biomarkers for treatment selection in colon cancer канала ImedexCME
As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016.
In this presentation, Dr. Christopher H. Lieu discusses the use of biomarkers for colon cancer treatment selection.
Earn accreditation for this activity at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205
© 2016 Imedex, LLC.
Видео Biomarkers for treatment selection in colon cancer канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Update: Left versus right sided colon cancers: Biomarkers versus biologyColorectal Cancer: Sequencing and Therapeutic Approaches in First- and Next-Line TreatmentColorectal Cancer with acquired resistance to EGFR antibodies: How to manage?Molecular Classification of Colon Cancer: New InsightsInitial Management of Metastatic CRC in 2019Colorectal Cancer: The Link Between the Immune Microenvironment and OutcomesHow to Approach the Patient With BRAF Mutant TumorColorectal Cancer - OverviewMultidisciplinary Tumor Board: A Challenging Patient With Colorectal CancerUSMLE GIT 10: Colon Cancer Mechanism and PathwaysHow to do MSI testing?Migraine Prevention: New Opportunities for Pain ReliefBRAF mutation – What does it mean? What are the complications of BRAF Inhibitors?MSI in CRC – Microsatellite instability in colorectal cancer–Please participate in our survey below!Cancer cell biology: mutated KRAS & reciprocal signallingCancer Immunotherapy: 2020 Research Update and a Look Ahead with Dr. Padmanee SharmaA Multidisciplinary Approach to Screening and Managing Peripheral Arterial DiseaseAML Treatment Challenges Who, When, and HowIntroduction to Cancer Biology (Part 1): Abnormal Signal TransductionKRAS mutation